{
  "docId": "019de076-2049-75e8-9528-894c783c20b2",
  "docSlug": "1f0c6538bd85906c2fdac9c48c149895",
  "documentTitle": "argenx SE | Investor Presentation Deck | 25 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 14,
  "pageCount": 25,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "other",
  "function": "present_framework",
  "density": "overcrowded",
  "nDataPoints": 4,
  "notes": "The slide outlines a clinical trial protocol timeline.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de076-2049-75e8-9528-894c783c20b2/14",
  "deckHref": "/decks/019de076-2049-75e8-9528-894c783c20b2",
  "deckJsonHref": "/decks/019de076-2049-75e8-9528-894c783c20b2.json",
  "deckAnchorHref": "/decks/019de076-2049-75e8-9528-894c783c20b2#slide-14",
  "components": [
    {
      "bbox": {
        "h": 0.09,
        "w": 0.44,
        "x": 0.28,
        "y": 0.84
      },
      "kind": "callout",
      "text": "Topline data expected 4Q 2023",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "baf891d4-c965-4779-9e7c-d0759f95eb9e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.68,
        "x": 0.26,
        "y": 0.33
      },
      "kind": "diagram",
      "text": "Trial timeline from week 0 to 24 with dosing phases",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f7382753-4295-40d4-9e70-2f15203f50ec",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.16,
        "x": 0.79,
        "y": 0.02
      },
      "kind": "image",
      "text": "advance SC logo",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "99b126f8-6b08-420e-a5c3-5ea0a1d1b7a5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.23,
        "x": 0.04,
        "y": 0.22
      },
      "kind": "list",
      "text": "Adult Chronic or Persistent ITP patients; 2 weeks screening; Mean platelet count <30x10^9/L; Stable concomitant ITP therapy allowed; Stratification: splenectomy, concomitant ITP therapy",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8cf7cd65-11d2-46e1-a9e5-34e6708acdbc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.72,
        "x": 0.18,
        "y": 0.65
      },
      "kind": "paragraph",
      "text": "Primary endpoint: Sustained platelet count (≥50x10^9/L) in ≥4/6 visits between weeks 19 and 24. Stringent endpoint in line with regulatory feedback, addressing platelet count variability. Secondary and exploratory endpoints center around extent of disease control to illustrate real-world viability",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "abc49b0b-1baf-4390-9c4c-8a3df7244e37",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.1,
        "x": 0.01,
        "y": 0.97
      },
      "kind": "source-note",
      "text": "q2w = every other week",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f2eb4b5d-88e0-4e8e-a940-004241b23968",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.25,
        "x": 0.03,
        "y": 0.04
      },
      "kind": "title",
      "text": "ITP ADVANCE-SC Trial",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5db80a5a-d550-475c-aa30-60e4aff534d6",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "AIDA Model",
      "slug": "aida-model",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "c6716720-cb59-4191-ae2b-163d702c7c6a",
      "evidence": "Primary endpoint: Sustained platelet count (≥50x10^9/L) in ≥4/6 visits between weeks 19 and 24.",
      "confidence": 0.7
    },
    {
      "name": "SCQA Framework",
      "slug": "scqa-framework",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "aab7ff5c-b7c9-424c-adfd-7996d8a78458",
      "evidence": "Primary endpoint: Sustained platelet count (≥50x10^9/L) in ≥4/6 visits between weeks 19 and 24.",
      "confidence": 0.6
    }
  ],
  "frameworks": [
    {
      "name": "timeline",
      "slug": null,
      "matchId": "eca0ef88-dded-417f-b9df-af622b8b0aff",
      "evidence": "Visual representation of trial phases over 24 weeks",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 15,
      "from": 13,
      "name": "Why Now",
      "slug": "15-why-now",
      "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
      "matchId": "ebeb26eb-b6f0-468f-a72f-dbe5b8c0b96b",
      "evidence": "The presentation provides a timeline of upcoming milestones and launches.",
      "position": 1,
      "objective": "Why is now the right time for argenx SE's products and growth strategy?",
      "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
      "confidence": 0.6,
      "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}